654 related articles for article (PubMed ID: 16000328)
41. A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation.
Suzaki Y; Hamada K; Nomi T; Ito T; Sho M; Kai Y; Nakajima Y; Kimura H
Eur Respir J; 2008 Apr; 31(4):783-9. PubMed ID: 18094012
[TBL] [Abstract][Full Text] [Related]
42. PACAP provides colonic protection against dextran sodium sulfate induced colitis.
Azuma YT; Hagi K; Shintani N; Kuwamura M; Nakajima H; Hashimoto H; Baba A; Takeuchi T
J Cell Physiol; 2008 Jul; 216(1):111-9. PubMed ID: 18205183
[TBL] [Abstract][Full Text] [Related]
43. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
Naito Y; Takagi T; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Yanagisawa R; Inoue K; Takano H; Satoh M; Yoshida N; Okanoue T; Yoshikawa T
Int J Mol Med; 2004 Aug; 14(2):191-6. PubMed ID: 15254764
[TBL] [Abstract][Full Text] [Related]
44. A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses.
Yang YF; Mukai T; Gao P; Yamaguchi N; Ono S; Iwaki H; Obika S; Imanishi T; Tsujimura T; Hamaoka T; Fujiwara H
Eur J Immunol; 2002 Aug; 32(8):2124-32. PubMed ID: 12209624
[TBL] [Abstract][Full Text] [Related]
45. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
46. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
[TBL] [Abstract][Full Text] [Related]
47. PPARα contributes to colonic protection in mice with DSS-induced colitis.
Azuma YT; Nishiyama K; Matsuo Y; Kuwamura M; Morioka A; Nakajima H; Takeuchi T
Int Immunopharmacol; 2010 Oct; 10(10):1261-7. PubMed ID: 20650341
[TBL] [Abstract][Full Text] [Related]
48. Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis.
Kwon JH; Keates AC; Anton PM; Botero M; Goldsmith JD; Kelly CP
Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1075-83. PubMed ID: 16099872
[TBL] [Abstract][Full Text] [Related]
49. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
[TBL] [Abstract][Full Text] [Related]
50. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
[TBL] [Abstract][Full Text] [Related]
51. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
52. Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model.
Takama Y; Miyagawa S; Yamamoto A; Firdawes S; Ueno T; Ihara Y; Kondo A; Matsunami K; Otsuka H; Fukuzawa M
Transpl Immunol; 2011 Jul; 25(1):49-55. PubMed ID: 21515370
[TBL] [Abstract][Full Text] [Related]
53. Selective expression and cellular localization of pro-inflammatory chemokine ligand/receptor pairs in the sciatic nerves of a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
Xia RH; Yosef N; Ubogu EE
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):388-98. PubMed ID: 20500551
[TBL] [Abstract][Full Text] [Related]
54. An independent subset of TLR expressing CCR2-dependent macrophages promotes colonic inflammation.
Platt AM; Bain CC; Bordon Y; Sester DP; Mowat AM
J Immunol; 2010 Jun; 184(12):6843-54. PubMed ID: 20483766
[TBL] [Abstract][Full Text] [Related]
55. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
[TBL] [Abstract][Full Text] [Related]
56. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.
Sakata A; Ochiai T; Shimeno H; Hikishima S; Yokomatsu T; Shibuya S; Toda A; Eyanagi R; Soeda S
Immunology; 2007 Sep; 122(1):54-64. PubMed ID: 17451462
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
[TBL] [Abstract][Full Text] [Related]
58. Role of CXCR3 and CCR5 in allograft rejection.
Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
[TBL] [Abstract][Full Text] [Related]
59. CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis.
Holst PJ; Orskov C; Qvortrup K; Christensen JP; Thomsen AR
J Virol; 2007 Sep; 81(18):10101-12. PubMed ID: 17626099
[TBL] [Abstract][Full Text] [Related]
60. Phenyl methimazole suppresses dextran sulfate sodium-induced murine colitis.
Benavides U; Gonzalez-Murguiondo M; Harii N; Lewis CJ; Sakhalkar HS; Deosarkar SP; Kurjiaka DT; Dagia NM; Goetz DJ; Kohn LD
Eur J Pharmacol; 2010 Sep; 643(1):129-38. PubMed ID: 20550948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
